Title:
NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
Document Type and Number:
WIPO Patent Application WO/2011/117391
Kind Code:
A3
Abstract:
The present invention relates to a novel pharmaceutical composition free of gastric coating comprising anagrelide hydrochloride in combination with a non-pH dependent polymer and a pharmaceutically acceptable watersoluble acid and its use for the treatment of essential thrombocythemia.
Inventors:
WIDMANN RUDOLF (AT)
STRIEDER GEORG (AT)
STRIEDER GEORG (AT)
Application Number:
PCT/EP2011/054628
Publication Date:
January 19, 2012
Filing Date:
March 25, 2011
Export Citation:
Assignee:
AOP ORPHAN PHARMACEUTICALS AG (AT)
WIDMANN RUDOLF (AT)
STRIEDER GEORG (AT)
WIDMANN RUDOLF (AT)
STRIEDER GEORG (AT)
International Classes:
A61K31/517; A61K9/20
Foreign References:
US20040062800A1 | 2004-04-01 | |||
US20040028729A1 | 2004-02-12 |
Attorney, Agent or Firm:
LOIDL, Manuela et al. (Donau-City-Straße 1, Vienna, AT)
Download PDF: